Scientists have identified five specific blood proteins that can accurately predict a person's risk for developing a serious ...

For the period, Gilead's revenue clocked in at $6.67 billion, essentially flat over the same quarter of 2024. The company attributed this to sales declines of COVID drug Veklury and oncology products.

Two of Gilead Sciences' most important drugs missed sales expectations late Thursday. Gilead stock fell early Friday.

Scientists have identified five specific blood proteins that can accurately predict a person's risk for developing a serious form of liver disease as early as 16 years before they experience symptoms, ...

Experiments in mice infected with the SARS-CoV-2 virus revealed that the immune cell class in question, called nerve and ...

The company's first-quarter revenue slipped 0.3% year-over-year to $6.67 billion, while analysts surveyed by Visible Alpha ...

A new study on Lyme disease sheds light on the persistence of symptoms; another new study points to an antibiotic that may be ...

Scientists believe they know what causes the treated infection to mimic chronic illness: the body may be responding to remnants of the bacteria that causes Lyme that tend to pool in the liver and ...

Symptoms that persist long after Lyme disease is treated are not uncommon - a 2022 study found that 14% of patients who were diagnosed and treated early with antibiotic therapy would still develop ...

The United States has seen progress in reducing certain cancer risks, as overall smoking rates remain on a decline.

Tom Kirk, 26, hit rock bottom in March last year and was told that his kidneys and liver were functioning at 20 per cent after six years of taking ketamine daily. Tom had first taken the drug at ...